Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T64795 | Target Info | |||
Target Name | Voltage-gated calcium channel alpha Cav3.1 (CACNA1G) | ||||
Synonyms | Voltage-gated calcium channel alpha subunit Cav3.1; Voltage-dependent T-type calcium channel; NBR13; Cav3.1c; CACNA1G | ||||
Target Type | Successful Target | ||||
Gene Name | CACNA1G | ||||
Biochemical Class | Voltage-gated ion channel | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine | Ligand Info | |||
Canonical SMILES | CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCCCCCCC | ||||
InChI | 1S/C41H82NO8P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-40(43)47-37-39(38-49-51(45,46)48-36-35-42)50-41(44)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h39H,3-38,42H2,1-2H3,(H,45,46)/t39-/m1/s1 | ||||
InChIKey | LVNGJLRDBYCPGB-LDLOPFEMSA-N | ||||
PubChem Compound ID | 447078 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6KZO membrane protein | ||||||
Method | Electron microscopy | Resolution | 3.30 Å | Mutation | No | [1] |
PDB Sequence |
NPWFERISML
89 VILLNCVTLG99 MFRPCEDIAC109 DSQRCRILQA119 FDDFIFAFFA129 VEMVVKMVAG 149 DTWNRLDFFI159 VIAGMLEYSS177 AVRTVRVLRP187 LRAINRVPSM197 RILVTLLLDT 207 LPMLGNVLLL217 CFFVFFIFGI227 VGVQLWAGLL237 RNRCFLPENF247 SLPLSVDLER 257 YYQTENEDES267 PFICSQPREN277 GMRSCRSVPT287 LRCVNWNQYY320 TNCSAGEHNP 330 FKGAINFDNI340 GYAWIAIFQV350 ITLEGWVDIM360 YFVMDAHSFY370 NFIYFILLII 380 VGSFFMINLC390 LVVIATQFSY744 FGRGIMIAIL754 VNTLSMGIEY764 HEQPEELTNA 774 LEISNIVFTS784 LFALEMLLKL794 LVYGPFGYIK804 NPYNIFDGVI814 VVISVWSVLR 834 TFRLMRVLKL844 VRFLPALQRQ854 LVVLMKTMDN864 VATFCMLLML874 FIFIFSILGM 884 HLFGCKFALP901 DRKNFDSLLW911 AIVTVFQILT921 QEDWNKVLYN931 GMASTSSWAA 941 LYFIALMTFG951 NYVLFNLLVA961 ILVEGFQAKM1254 FDHVVLVIIF1264 LNCITIAMER 1274 PKIDPHSAER1284 IFLTLSNYIF1294 TAVFLAEMTV1304 KVVALGSSWN1324 VLDGLLVLIS 1334 VIDILVSMVS1344 DSILGMLRVL1357 RLLRTLRPLR1367 VISRAQGLKL1377 VVETLMSSLK 1387 PIGNIVVICC1397 AFFIIFGILG1407 VQLFKGKFFV1417 CQGEDTRNIT1427 NKSDCAEASY 1437 RWVRHKYNFD1447 NLGQALMSLF1457 VLASKDGWVD1467 IMYDGLDAVG1477 VDQQPIMNHN 1487 PWMLLYFISF1497 LLIVAFFVLN1507 MFVGVVVENF1517 HDLFITGVIG1599 LNVVTMAMEH 1609 YQQPQILDEA1619 LKICNYIFTV1629 IFVLESVFKN1653 QLDLAIVLLS1663 IMGITLEEIE 1673 VNASLPINPT1683 IIRIMRVLRI1693 ARVLKLLKMA1703 VGMRALLDTV1713 MQALPQVGNL 1723 GLLFMLLFFI1733 FAALGVELFG1743 DLECDETHPC1753 EGLGRHATFR1763 NFGMAFLTLF 1773 RVSTGDNWNG1783 IMKDTLRDYN1800 TVISPIYFVS1810 FVLTAQFVLV1820 NVVIAVLMKH 1830 LEESNKE
|
|||||
|
LEU92
4.967
CYS95
4.670
VAL96
4.737
GLY99
4.552
MET100
3.931
MET197
3.566
LEU208
3.241
PRO209
4.488
LEU211
3.340
GLY212
4.278
LEU215
3.486
VAL221
4.600
PHE222
3.039
ILE224
3.583
PHE225
3.923
VAL228
4.327
LEU232
4.125
ASN277
4.094
MET279
4.390
ASN339
3.619
ILE340
4.360
GLY341
4.012
TYR342
3.447
TRP344
3.884
ILE345
4.267
PHE348
4.338
ILE351
4.728
THR352
3.989
LEU353
3.856
HIS367
3.453
SER368
3.645
PHE369
3.445
TYR370
3.658
ASN371
4.315
PHE372
4.277
ILE373
4.709
TYR374
4.420
ILE376
4.080
LEU377
4.349
ILE379
3.753
ILE380
3.496
VAL381
4.723
SER383
4.922
PHE384
3.899
ILE387
3.443
ASN388
4.731
CYS390
3.986
SER831
4.577
VAL832
4.271
THR835
3.524
PHE836
4.053
LEU838
3.645
MET839
3.755
VAL865
4.695
CYS869
2.554
MET870
2.948
LEU871
4.839
LEU872
3.758
MET873
3.725
LEU874
4.510
ILE876
4.065
PHE877
4.660
SER908
3.060
LEU909
3.734
LEU910
2.995
TRP911
4.476
ILE913
3.569
PHE917
3.533
LEU920
2.965
THR921
3.089
GLN922
2.776
SER938
3.608
TRP939
3.855
ALA941
4.847
LEU942
4.563
ILE945
3.121
MET948
4.503
THR949
3.524
ASN952
3.349
TYR953
4.372
LEU955
3.737
PHE956
4.590
LEU958
4.324
LEU959
4.675
VAL1393
4.169
CYS1396
3.764
PHE1400
4.287
ILE1402
4.082
PHE1403
4.772
LEU1406
4.017
PHE1457
4.571
ALA1460
3.727
SER1461
4.222
LYS1462
3.443
VAL1476
4.732
HIS1486
3.020
ASN1487
2.963
PRO1488
3.625
TRP1489
3.591
MET1490
3.875
LEU1491
4.151
LEU1492
3.467
TYR1493
4.392
ILE1495
3.729
SER1496
3.468
LEU1498
4.623
LEU1499
3.740
VAL1501
4.708
ALA1502
3.610
PHE1503
4.377
VAL1505
3.868
LEU1506
3.669
VAL1603
4.929
ALA1606
3.755
MET1607
4.300
HIS1609
3.826
TYR1610
4.133
GLN1611
3.750
THR1683
4.166
ARG1686
3.919
ILE1687
2.881
VAL1690
3.993
LEU1691
3.638
ILE1693
3.742
PRO1718
4.462
VAL1720
3.665
GLY1721
3.713
ASN1722
4.102
GLY1724
3.880
LEU1725
4.242
PHE1727
4.797
MET1728
3.110
PHE1731
4.372
ASN1764
4.204
PHE1765
4.913
GLY1766
2.528
MET1767
2.509
PHE1769
4.230
LEU1770
4.004
PHE1773
3.982
SER1776
4.438
THR1777
3.725
LEU1813
3.825
GLN1816
3.705
LEU1819
3.712
|
|||||
PDB ID: 6KZP calcium channel-ligand | ||||||
Method | Electron microscopy | Resolution | 3.10 Å | Mutation | No | [1] |
PDB Sequence |
NPWFERISML
89 VILLNCVTLG99 MFRPCEDIAC109 DSQRCRILQA119 FDDFIFAFFA129 VEMVVKMVAG 149 DTWNRLDFFI159 VIAGMLEYSL169 DLQNVSFSAV179 RTVRVLRPLR189 AINRVPSMRI 199 LVTLLLDTLP209 MLGNVLLLCF219 FVFFIFGIVG229 VQLWAGLLRN239 RCFLPENFSL 249 PLSVDLERYY259 QTENEDESPF269 ICSQPRENGM279 RSCRSVPTLR289 CVNWNQYYTN 322 CSAGEHNPFK332 GAINFDNIGY342 AWIAIFQVIT352 LEGWVDIMYF362 VMDAHSFYNF 372 IYFILLIIVG382 SFFMINLCLV392 VIATQFSETK402 QREIVDSKYF745 GRGIMIAILV 755 NTLSMGIEYH765 EQPEELTNAL775 EISNIVFTSL785 FALEMLLKLL795 VYGPFGYIKN 805 PYNIFDGVIV815 VISVWEIVSV832 LRTFRLMRVL842 KLVRFLPALQ852 RQLVVLMKTM 862 DNVATFCMLL872 MLFIFIFSIL882 GMHLFGCKFA892 SLPDRKNFDS908 LLWAIVTVFQ 918 ILTQEDWNKV928 LYNGMASTSS938 WAALYFIALM948 TFGNYVLFNL958 LVAILVEGFQ 968 FRLLCHRIIT1251 HKMFDHVVLV1261 IIFLNCITIA1271 MERPKIDPHS1281 AERIFLTLSN 1291 YIFTAVFLAE1301 MTVKVVALGS1321 SWNVLDGLLV1331 LISVIDILVS1341 MVSKILGMLR 1355 VLRLLRTLRP1365 LRVISRAQGL1375 KLVVETLMSS1385 LKPIGNIVVI1395 CCAFFIIFGI 1405 LGVQLFKGKF1415 FVCQGEDTRN1425 ITNKSDCAEA1435 SYRWVRHKYN1445 FDNLGQALMS 1455 LFVLASKDGW1465 VDIMYDGLDA1475 VGVDQQPIMN1485 HNPWMLLYFI1495 SFLLIVAFFV 1505 LNMFVGVVVE1515 NFHYLDLFIT1595 GVIGLNVVTM1605 AMEHYQQPQI1615 LDEALKICNY 1625 IFTVIFVLES1635 VFKLVAFGFR1645 RFFQDRWNQL1655 DLAIVLLSIM1665 GITLEEIEVN 1675 ASLPINPTII1685 RIMRVLRIAR1695 VLKLLKMAVG1705 MRALLDTVMQ1715 ALPQVGNLGL 1725 LFMLLFFIFA1735 ALGVELFGDL1745 ECDETHPCEG1755 LGRHATFRNF1765 GMAFLTLFRV 1775 STGDNWNGIM1785 KDTLRDYNTV1802 ISPIYFVSFV1812 LTAQFVLVNV1822 VIAVLMKHLE 1832 ESNK
|
|||||
|
VAL184
4.915
LEU185
4.132
PHE222
3.986
ASN339
2.980
ILE340
4.656
GLY341
3.722
TYR342
3.629
TRP344
3.747
ILE345
3.700
LEU353
4.071
PHE369
3.849
TYR370
3.946
PHE372
4.018
ILE373
4.113
SER831
4.202
VAL832
3.643
THR835
3.175
PHE836
3.774
LEU838
4.528
MET839
3.149
LEU842
4.974
LEU872
4.208
MET873
4.736
ILE876
3.758
ILE878
4.263
PHE879
4.391
LEU882
3.777
LEU886
3.942
LYS890
3.302
LEU910
3.685
ILE913
3.814
VAL914
3.927
PHE917
3.651
SER935
3.182
THR936
3.305
SER937
3.200
SER938
3.588
TRP939
3.822
ALA940
3.916
ALA941
4.790
LEU942
4.486
TYR943
4.170
ILE945
3.724
ALA946
3.815
LEU1386
4.659
VAL1393
4.151
CYS1396
4.300
CYS1397
3.569
PHE1400
4.193
ILE1402
4.609
PHE1403
3.142
LEU1406
3.938
LEU1410
4.234
LYS1414
4.768
PHE1457
4.496
ALA1460
4.073
SER1461
4.473
LYS1462
4.535
ASN1487
3.244
PRO1488
3.882
TRP1489
3.677
MET1490
3.659
LEU1491
3.904
LEU1492
3.679
TYR1493
4.709
ILE1495
3.692
SER1496
3.931
LEU1499
4.319
ILE1500
4.726
VAL1501
4.635
VAL1505
3.557
MET1508
4.242
VAL1603
4.907
ALA1606
3.906
MET1607
4.085
HIS1609
3.881
TYR1610
4.546
GLN1611
4.654
ARG1763
3.569
ASN1764
3.518
GLY1766
3.897
MET1767
3.689
PHE1769
4.221
LEU1770
3.943
THR1777
3.591
VAL1812
4.481
LEU1813
3.564
THR1814
4.030
GLN1816
3.672
PHE1817
3.415
VAL1820
3.835
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Cryo-EM structures of apo and antagonist-bound human Ca(v)3.1. Nature. 2019 Dec;576(7787):492-497. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.